JAMIE FLYNN: Open Payments
NPI 1336161876 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,901 in 193 payments from 24 companies in 2025. Trend: 2023 $399 · 2024 $2,382 · 2025 $4,901
Food & beverage: $4,616Education: $285
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 36 | $1,137 |
| UCB, Inc. | 31 | $1,123 |
| Galderma Laboratories, L.P. | 25 | $260 |
| ABBVIE INC. | 11 | $225 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $214 |
| Arcutis Biotherapeutics, Inc. | 12 | $206 |
| E.R. Squibb & Sons, L.L.C. | 14 | $205 |
| Organon LLC | 8 | $205 |
| LEO Pharma Inc. | 9 | $151 |
| Amgen Inc. | 6 | $149 |
Products named: TREMFYA, Bimzelx, DUPIXENT, SKYRIZI, Zoryve, Sotyktu, Cabtreo, NEMLUVIO.
Industry payments across PA — which companies pay providers there.
